Suggested algorithm for reversing VKA in bleeding patients. *With acenocoumarol, consider merely reducing the dose because stopping may result in INR overcorrection. **Patients with older age, heart failure, cancer, or longer-acting VKAs. 4-F PCC, 4-factor prothrombin complex concentrate.